Smedsrud T, Dannevig B H, Tolleshaug H, Berg T
Dev Comp Immunol. 1984 Summer;8(3):579-88. doi: 10.1016/0145-305x(84)90090-9.
The uptake and degradation of a mannose-terminated glycoprotein, yeast invertase, in char (Salmo alpinus L.) tissue was studied after intravenously injection of the 125I-labelled protein. 125I-labelled formaldehyde-treated human serum albumin (fHSA) and native HSA was also injected for comparison. Labelled invertase was rapidly cleared from blood and at about the same rate as labelled fHSA (at 8 degrees C). Approximately 50% of the initial concentration remained in blood 15 min after the injection of the ligands. Acid soluble degradation products appeared in the circulation about 60 min after the injection of the proteins. 125I-labelled invertase was recovered in the liver, pronephros and kidney. The clearance of labelled invertase from blood and the uptake in the organs were inhibited by co-injection of excess unlabelled invertase. fHSA was taken up in the pronephros and kidney tissue, while HSA was not taken up in any organs. In vitro degradation of the labelled ligands was studied in isolated pronephros cells, which had taken up the proteins in vivo. The degradation of invertase in isolated cells was partly inhibited by ammonium chloride. Ammonium chloride and chloroquine inhibited degradation of fHSA, but not leupeptin. These results together suggest that invertase and fHSA were taken up in the organs described by the receptor-mediated endocytosis. The degradation was partly or wholly lysosomal.
静脉注射125I标记的甘露糖末端糖蛋白酵母转化酶后,研究了其在红点鲑(Salmo alpinus L.)组织中的摄取和降解情况。同时注射125I标记的甲醛处理的人血清白蛋白(fHSA)和天然HSA作为对照。标记的转化酶从血液中迅速清除,清除速率与标记的fHSA大致相同(在8℃时)。注射配体后15分钟,约50%的初始浓度仍留在血液中。注射蛋白质后约60分钟,循环中出现酸溶性降解产物。125I标记的转化酶在肝脏、前肾和肾脏中被回收。同时注射过量未标记的转化酶可抑制标记的转化酶从血液中的清除以及在器官中的摄取。fHSA在前肾和肾脏组织中被摄取,而HSA在任何器官中均未被摄取。在体内摄取了蛋白质的分离前肾细胞中研究了标记配体的体外降解。氯化铵部分抑制了分离细胞中转化酶的降解。氯化铵和氯喹抑制fHSA的降解,但不抑制亮抑酶肽。这些结果共同表明,转化酶和fHSA通过受体介导的内吞作用被摄取到所述器官中。降解部分或全部发生在溶酶体中。